SMYD3-mediated lysine methylation in the PH domain is critical for activation of AKT1

Yuichiro Yoshioka1,2, Takehiro Suzuki3, Yo Matsuo4

  • 1Section of Hematology/Oncology, Department of Medicine, The University of Chicago, MC2115 Chicago, IL 60637, USA.

Oncotarget
|September 15, 2016
PubMed

Insights

The protein lysine methyltransferase SMYD3 methylates AKT1 at lysine 14, a novel modification essential for AKT1 activation and cancer cell growth. This SMYD3-mediated methylation of AKT1 is a potential therapeutic target for anti-cancer treatments.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • AKT1 is a key serine/threonine kinase implicated in tumorigenesis and frequently overexpressed in cancers.
  • Post-translational modifications like phosphorylation and ubiquitination are known for AKT1, but methylation has not been previously reported.

Purpose of the Study:

  • To investigate the potential methylation of AKT1.
  • To identify the enzyme responsible for AKT1 methylation and elucidate its functional consequences in cancer.

Main Methods:

  • In vitro and in vivo methylation assays using protein lysine methyltransferase SMYD3.
  • Site-directed mutagenesis to substitute lysine 14 of AKT1.
  • Western blotting to assess AKT1 phosphorylation at threonine 308.
  • Cellular assays to evaluate plasma membrane accumulation and cancer cell growth rates.
  • SMYD3 knockdown and inhibitor treatments in cancer cells.

Main Results:

  • SMYD3 was identified as the enzyme that methylates lysine 14 (K14) in the PH domain of AKT1.
  • Methylation of AKT1 at K14 significantly reduced phosphorylation at threonine 308 (T308).
  • SMYD3 inhibition or knockdown attenuated AKT1 T308 phosphorylation in cancer cells.
  • K14 substitution diminished AKT1 plasma membrane localization and reduced cancer cell growth rates.

Conclusions:

  • SMYD3-mediated methylation of AKT1 at K14 is a critical regulatory mechanism for AKT1 activation.
  • This methylation event is essential for AKT1's role in promoting cancer cell proliferation.
  • SMYD3-mediated AKT1 methylation represents a promising therapeutic target for developing novel anti-cancer strategies.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.6K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
9.9K
Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
16.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.0K
Cytoskeletal Linker Proteins - Plakins01:09

Cytoskeletal Linker Proteins - Plakins

Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...
3.0K